Doxycycline and tissue repair in rats

Area of Science:

• Biomedical Engineering
• Pharmacology
• Tissue Engineering

Background:

• Collagen turnover is crucial for tissue repair, but dysregulation leads to pathologic remodeling.
• Pharmacologic interventions targeting collagen synthesis or degradation are of therapeutic interest.
• Tetracyclines, like doxycycline, inhibit collagen synthesis, degradation, and angiogenesis, offering potential for modulating tissue repair.

Purpose of the Study:

• To investigate the effects of doxycycline on tissue repair using a subcutaneous rat pouch model.
• To assess doxycycline's impact on collagen turnover, matrix metalloproteinase (MMP) activity, and neovascularization.
• To determine doxycycline's dual role in modulating early tissue formation and later tissue resorption.

Main Methods:

• A subcutaneous rat pouch model induced by croton oil was used for 5 weeks.
• Doxycycline treatment (40 mg/kg daily) was compared to untreated controls.
• Assessed pouch tissue weight, hydroxyproline (collagen marker), MMP activity (zymography), vascularity, and serum markers of collagen degradation (ICTP).

Main Results:

• Doxycycline attenuated early tissue formation, reducing weight, collagen, MMP2 activity, and vascularity.
• In vitro studies confirmed doxycycline's dose-dependent inhibition of gelatinolytic activity.
• Later, doxycycline increased pouch size and collagen, while reducing serum ICTP, indicating inhibited resorption due to MMP inhibition.

Conclusions:

• Doxycycline initially inhibits tissue formation by reducing angiogenesis and modulating collagen turnover.
• Doxycycline retards subsequent tissue resorption by inhibiting MMPs, thus altering collagen degradation.
• Doxycycline exhibits a multifaceted pharmacological profile for modifying diverse aspects of tissue repair in rats.